Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Stock Price Down 1.2% – What’s Next?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) was down 1.2% during mid-day trading on Wednesday . The company traded as low as $0.3131 and last traded at $0.3193. Approximately 2,998,141 shares traded hands during mid-day trading, a decline of 18% from the average daily volume of 3,644,772 shares. The stock had previously closed at $0.3231.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on GRML. Weiss Ratings upgraded Greenland Mines Ltd. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, June 9th. Wall Street Zen raised Greenland Mines Ltd. Common Stock to a “sell” rating in a research note on Saturday, May 2nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

Greenland Mines Ltd. Common Stock Price Performance

The company has a market cap of $35.16 million, a price-to-earnings ratio of -0.91 and a beta of 6.94. The business’s fifty day simple moving average is $0.41 and its two-hundred day simple moving average is $0.40.

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) last posted its earnings results on Wednesday, May 20th. The company reported ($0.15) EPS for the quarter.

Hedge Funds Weigh In On Greenland Mines Ltd. Common Stock

Hedge funds have recently made changes to their positions in the company. Jane Street Group LLC purchased a new stake in shares of Greenland Mines Ltd. Common Stock in the 2nd quarter valued at about $26,000. Brummer Multi Strategy AB purchased a new stake in Greenland Mines Ltd. Common Stock in the fourth quarter valued at approximately $175,000. Geode Capital Management LLC lifted its stake in Greenland Mines Ltd. Common Stock by 51.8% in the fourth quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock valued at $142,000 after buying an additional 167,905 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in shares of Greenland Mines Ltd. Common Stock in the fourth quarter valued at approximately $126,000. Finally, XTX Topco Ltd grew its position in shares of Greenland Mines Ltd. Common Stock by 101.2% during the fourth quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock worth $46,000 after acquiring an additional 80,768 shares during the last quarter. Hedge funds and other institutional investors own 20.07% of the company’s stock.

About Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.